Tremelimumab (Ticilimumab) is a fully humanized monoclonal antibody specific for cytotoxic T-lymphocyte antigen-4 (CTLA-4) and can be used for metastatic melanoma research.
Purity:
99.0%
CAS Number:
[745013-59-6]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted